You are here:

Treatments

10 June 2016

Amy Bowen from the MS Trust explains how it gets to the nub of the issues surrounding stem cell therapy for MS and why it's time for a roadmap for making the treatment safe and widely available on the NHS.

Read more

20 January 2016
magnifying glass

In short, yes it could. The recent Panorama programme focussed on people with relapsing MS, but many people are asking whether people with progressive MS could be helped too.

In this blog, Jane from the Information Team looks at some of the research so far, what’s possible now and where we might expect to see further progress in the future.

Read more

02 December 2015
Is stem cell therapy right for my MS

There is an increasing interest in stem cell therapy for multiple sclerosis. Perhaps you are debating whether it could be a treatment option for you either now or in the future?

In this blog, Jane from the Information Team at the MS Trust, looks at some of the issues surrounding this largely experimental treatment.

Read more

07 October 2015
A new focus on brain health: Amy Bowen reports from ECTRIMS 2015

Amy Bowen, our Director of Service Development, reports from ECTRIMS 2015 on what is widely expected to be the most significant MS conference for many years

Read more

28 September 2015
Choosing my disease modifying drug; Kate's story

Kate Milne, who was diagnosed with MS in 2012, blogs about choosing a disease modifying drug: "I think anybody else facing this decision needs to look at what is important for them."

Read more

10 August 2015

When Ema was diagnosed, injectable MS drugs seemed to be keeping symptoms under control. But a severe relapse made her consider more powerful treatments

Read more

10 August 2015

Professor Gavin Giovannoni is Chair of Neurology at Barts and The London School of Medicine and Dentistry and is widely credited with popularising the idea of early treatment and treating to target NEDA in MS

Read more

10 August 2015

In the past, people diagnosed with MS were sometimes told to ‘wait and see’ how their MS developed before making decisions about whether to consider disease modifying drugs. But the new MS treatment guidelines published by the Association of British Neurologists in June recommend that people with MS should begin treatment as early as possible.

Read more

17 June 2015

Earlier this week our Director of Service Development, Amy Bowen, was asked by a national paper to comment on the issue of medicinal cannabis in MS, and in particular Sativex, a drug used to treat muscle spasticity. When published, Amy’s interview was edited down to a couple of lines in a larger article. Here she explores some of the difficult issues around cannabis use in MS in more depth

Read more

11 May 2015

Dr Jeremy Chataway is a consultant neurologist at the National Hospital for Neurology and Neurosurgery in London and has been involved in MS research for many years, most recently into the effects of simvastatin on progressive MS. He’s now leading on the MS-SMART trial, looking at the effects of three drugs which are already used for other conditions on people with secondary progressive MS. The trial is recruiting throughout 2015.

Read more

01 May 2015

The 67th annual meeting of the American Academy of Neurology took place in Washington, April 18-25. Pre-meeting media announcements created high expectations for several presentations at the meeting, particularly treatments which may promote remyelination and neuroprotection and potentially slow the build-up of disability.

Read more

16 May 2014

As this edition of Open Door hits your doormat the preliminary results of the Department of Health Risk-sharing Scheme (RSS) will have been presented at the Association of British Neurologists meeting, and by the next edition we hope the full results will have been published in the Lancet or BMJ.

Read more

16 May 2014

MS rehab services vary depending on where you live. If you have an MS nurse, they are often the best people to ask what’s available locally. If you have an MS therapy centre near you they might also be able to help you find a physiotherapist or other rehab professionals. You might need a referral from your GP to access some of these services.

Read more

13 February 2012

In my day to day work I spend a lot of time of Facebook and Twitter, I post news articles and pick up on questions people might have for the MS Trust. I notice a lot of people (including myself) get very confused about drugs that are in development for MS. You see a news item about something like Sativex getting a licence, which will excite a lot of people thinking this entitles them to be able to have the treatment, but when they try to get it, they get turned down as the drug is not yet approved by the NHS. 

Read more

10 November 2011
Baclofen pump

Intrathecal baclofen (ITB) is an invasive treatment for spasticity and spasms. It used to be thought of as a last resort but more recently both health professionals and people with MS are realising it can help to keep people mobile and well without the side effects often experienced by oral medications. Dr Val Stevenson discusses the treatment and Carmel Mackey, who uses a baclofen pump, talks about how it has affected her life

Read more

05 May 2011

Mindfulness involves learning to bring our full attention to our experience moment by moment in a kind and non-judgemental way so that we can be aware of what is really happening in our bodies, our minds and emotions and our environment.  Vanessa Hope considers how the approach might help people with MS.

Read more